Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-04-08

Clinical Trial Update: Betaine in Patients With Nonalcoholic Steatohepatitis [Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 2 study of betaine in patients with nonalcoholic steatohepatitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Betaine (betaine (trimethylglycine))

Snippet

Sponsor: Mayo Clinic | Conditions: Nonalcoholic Steatohepatitis | Phase 2 | Status: COMPLETED